Natixis Advisors LLC Cuts Stake in Oscar Health, Inc. (NYSE:OSCR)

Natixis Advisors LLC lowered its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 3.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,034 shares of the company’s stock after selling 1,081 shares during the period. Natixis Advisors LLC’s holdings in Oscar Health were worth $459,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Alliancebernstein L.P. grew its holdings in shares of Oscar Health by 1.1% in the fourth quarter. Alliancebernstein L.P. now owns 243,160 shares of the company’s stock valued at $3,268,000 after purchasing an additional 2,600 shares during the period. Russell Investments Group Ltd. grew its position in Oscar Health by 63.3% in the fourth quarter. Russell Investments Group Ltd. now owns 216,782 shares of the company’s stock worth $2,914,000 after acquiring an additional 84,029 shares during the period. Raymond James Financial Inc. purchased a new position in Oscar Health in the fourth quarter worth approximately $6,613,000. Summit Investment Advisors Inc. grew its position in Oscar Health by 5.8% in the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company’s stock worth $280,000 after acquiring an additional 1,141 shares during the period. Finally, Barclays PLC grew its position in Oscar Health by 10.8% in the fourth quarter. Barclays PLC now owns 361,062 shares of the company’s stock worth $4,852,000 after acquiring an additional 35,244 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on OSCR shares. UBS Group restated a “sell” rating and issued a $11.00 price objective (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Baird R W lowered shares of Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, July 25th. Barclays reduced their price objective on shares of Oscar Health from $17.00 to $11.00 and set an “underweight” rating on the stock in a report on Wednesday, July 23rd. Piper Sandler lowered shares of Oscar Health from an “overweight” rating to a “neutral” rating and set a $14.00 price objective on the stock. in a report on Monday, July 14th. Finally, Raymond James Financial lowered shares of Oscar Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 24th. Six research analysts have rated the stock with a sell rating and four have given a hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average price target of $12.21.

Oscar Health Stock Performance

Shares of OSCR stock opened at $15.63 on Tuesday. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The business has a 50 day moving average of $15.93 and a two-hundred day moving average of $14.83. Oscar Health, Inc. has a 52 week low of $11.20 and a 52 week high of $23.79. The company has a market cap of $3.98 billion, a P/E ratio of -19.30 and a beta of 1.86.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, beating the consensus estimate of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The company had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. During the same quarter last year, the business earned $0.20 earnings per share. Oscar Health’s revenue was up 29.0% compared to the same quarter last year. As a group, analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.